Literature DB >> 11813385

Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice.

E A Field1, S Fear, S M Higham, R S Ireland, J Rostron, R M Willetts, L P Longman.   

Abstract

OBJECTIVE: To study the prevalence of xerostomia in an English population, attending general dental practice and relate it to age, medication and gender. DESIGN STUDY: Cross-sectional.
SETTING: Five General Dental Practices in Merseyside, North of England.
SUBJECTS: 1,103 adult patients attending for routine dental care. INTERVENTION: Questionnaire administered by dentists. MAIN OUTCOME MEASURES: Age, gender, systemic medication, reported oral dryness.
RESULTS: 1,103 patients (654 females) were recruited, of whom 427 (39%) were aged 60 years or older. 26% of patients reported taking medication. The overall prevalence of xerostomia was 12.7% (males--10.3%, females 14.4%). Age, medication and female gender were found to be significant risk factors for xerostomia, using logistic regression analysis.
CONCLUSIONS: The prevalence of xerostomia (12.7%) in an English population was lower than reported in previous North American and Swedish studies. Medication was a significant risk factor for xerostomia and a better predictor of risk status, than either age or gender.

Entities:  

Mesh:

Year:  2001        PMID: 11813385     DOI: 10.1111/j.1741-2358.2001.00021.x

Source DB:  PubMed          Journal:  Gerodontology        ISSN: 0734-0664            Impact factor:   2.980


  15 in total

1.  Clinical diagnosis of hyposalivation in hospitalized patients.

Authors:  Soraya de Azambuja Berti-Couto; Paulo Henrique Couto-Souza; Reinhilde Jacobs; Olivia Nackaerts; Izabel Regina Fischer Rubira-Bullen; Fernando Henrique Westphalen; Samuel Jorge Moysés; Sérgio Aparecido Ignácio; Maitê Barroso da Costa; Ana Lúcia Tolazzi
Journal:  J Appl Oral Sci       Date:  2012 Mar-Apr       Impact factor: 2.698

2.  Oral dryness and Sjögren's: an update.

Authors:  P J Shirlaw; A Khan
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

3.  Xerostomia and medications among 32-year-olds.

Authors:  William Murray Thomson; Richie Poulton; Jonathan Mark Broadbent; Shaima Al-Kubaisy
Journal:  Acta Odontol Scand       Date:  2006-08       Impact factor: 2.331

4.  Xerostomia and medication: a cross-sectional study in long-term geriatric wards.

Authors:  A Desoutter; M Soudain-Pineau; F Munsch; C Mauprivez; T Dufour; J-L Coeuriot
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

5.  Medication Use Among Patients Reporting Xerostomia of an Academic Dental Clinic.

Authors:  Michael P Krajewski; QingXiang Mo; Chi-Hua Lu; Albert Cantos; Steve Feuerstein; Michael J Brandt; Robert G Wahler
Journal:  J Pharm Technol       Date:  2022-07-15

6.  Anticholinergic medication and dental caries status in middle-aged xerostomia patients-a retrospective study.

Authors:  Mayank Kakkar; Abdul Basir Barmak; Szilvia Arany
Journal:  J Dent Sci       Date:  2021-12-29       Impact factor: 3.719

Review 7.  Anticholinergic medication: Related dry mouth and effects on the salivary glands.

Authors:  Szilvia Arany; Dorota T Kopycka-Kedzierawski; Thomas V Caprio; Gene E Watson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2021-08-29

8.  Path generator control system and virtual compliance calculator for maxillofacial massage robots.

Authors:  Hiroyuki Ishii; Hiroki Koga; Yuichi Obokawa; Jorge Solis; Atsuo Takanishi; Akitoshi Katsumata
Journal:  Int J Comput Assist Radiol Surg       Date:  2009-07-09       Impact factor: 2.924

9.  Where Dysphagia Begins: Polypharmacy and Xerostomia.

Authors:  Stephen Marcott; Karuna Dewan; Miki Kwan; Fred Baik; Yu-Jin Lee; Davud Sirjani
Journal:  Fed Pract       Date:  2020-05

Review 10.  The stomatognathic system in the elderly. Useful information for the medical practitioner.

Authors:  Anastassia E Kossioni; Anastasios S Dontas
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.